CD4 and infection: CD4+ T cell activation in response to the MP BA.2 subvariant was increased between pre-immune timepoint and 2 to 8 weeks post-infection (p<0.01) and between 2nd dose + 4 weeks and 2 to 8 weeks post-infection (p<0.001) (Figure 4D).